Famciclovir and Thrombocytopenia - a phase IV clinical study of FDA data
Thrombocytopenia is found among people who take Famciclovir, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Famciclovir and have Thrombocytopenia. It is created by eHealthMe based on reports of 2,610 people who have side effects when taking Famciclovir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
2,610 people reported to have side effects when taking Famciclovir.
Among them, 133 people (5.1%) have Thrombocytopenia.
What is Famciclovir?
Famciclovir has active ingredients of famciclovir. It is often used in herpes zoster. eHealthMe is studying from 2,708 Famciclovir users for its effectiveness, alternative drugs and more.
What is Thrombocytopenia?
Thrombocytopenia (decrease of platelets in blood) is found to be associated with 3,710 drugs and 4,291 conditions by eHealthMe.
Number of Famciclovir and Thrombocytopenia reports submitted per year:
Time on Famciclovir when people have Thrombocytopenia *:
Gender of people who have Thrombocytopenia when taking Famciclovir*:
Age of people who have Thrombocytopenia when taking Famciclovir *:
Common drugs people take besides Famciclovir *:
Common side effects people have besides Thrombocytopenia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Famciclovir and have Thrombocytopenia?Check whether Thrombocytopenia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
Alternative drugs to, pros and cons of Famciclovir:
- Famciclovir (2,708 reports)
Thrombocytopenia treatments and more:
- Thrombocytopenia (226,205 reports)
COVID vaccines that are related to Thrombocytopenia:
- Thrombocytopenia in Moderna COVID Vaccine
- Thrombocytopenia in Pfizer BioNTech Covid Vaccine
- Thrombocytopenia in Johnson and Johnson Covid Vaccine
How severe was Thrombocytopenia and when was it recovered:
Expand to all the drugs that have ingredients of famciclovir:
Common drugs associated with Thrombocytopenia:
All the drugs that are associated with Thrombocytopenia:
- Thrombocytopenia (3,710 drugs)
Common conditions associated with Thrombocytopenia:
All the conditions that are associated with Thrombocytopenia:
- Thrombocytopenia (4,291 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on famciclovir (the active ingredients of Famciclovir) and Famciclovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.